ST

Sushil Thapa Chhetri

Director Director DIN 05346994
DIN 05346994 First appointment Aug 2012 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Sushil Thapa Chhetri

Data last updated:

Sushil Thapa Chhetri was a Director at Regen Medtec Private Limited (2012–2019) and Director at Six Sigma Exim Private Limited (from 2013). The companies operate in Healthcare.

DIN 05346994
Primary Designation Director
Industry Healthcare
First Appointment 30 Aug 2012
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Regen Medtec Private Limited U85100DL2012PTC241390
Director30 Aug 20122012Active
Six Sigma Exim Private Limited U74900DL2013PTC257946
Director16 Sep 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Six Sigma Exim Private Limited
Regen Medtec Private Limited
Premium access

Shareholding and investment profile for Sushil Thapa Chhetri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sushil Thapa Chhetri

Sushil Thapa Chhetri was first appointed on 30 Aug 2012 as Director at Regen Medtec Private Limited. The most recent appointment on record is 16 Sep 2013 at Six Sigma Exim Private Limited.

Sushil Thapa Chhetri held 2 earlier board appointments: Regen Medtec Private Limited (Director, 30 Aug 2012 to 15 Apr 2019); Six Sigma Exim Private Limited (Director, from 16 Sep 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available